| Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema (NCT03641144) | Sun Yat-sen University | 2018-06-01 |
| Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema (NCT03583242) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2018-05-23 |
| A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) (NCT03511898) | ThromboGenics | 2018-05-18 |
| Mean Visual Acuity Changes Following Five Injections of Aflibercept (NCT02645266) | McMaster University | 2018-05-01 |
| Micropulse for Suppression of Diabetic Macular Edema (NCT03519581) | University of California, Davis | 2018-04-20 |
| Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection (NCT03297684) | Advanced Eye Research Associates | 2018-04-11 |
| Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME (NCT03384524) | Andrew Moshfeghi, MD, MBA | 2018-03-01 |
| Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) (NCT03466099) | KalVista Pharmaceuticals, Ltd. | 2018-02-16 |
| Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema (NCT05736081) | Asociación para Evitar la Ceguera en México | 2018-02-15 |
| Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema (NCT03598205) | Fondazione G.B. Bietti, IRCCS | 2018-02-05 |
| Effect of Dexamethasone Implant on Optic Disc (NCT03927118) | Bulent Ecevit University | 2018-02-01 |
| A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema (NCT03397264) | Opthea Limited | 2018-01-16 |
| PROMINENT-Eye Ancillary Study (Protocol AD) (NCT03345901) | Jaeb Center for Health Research | 2018-01-15 |
| Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema (NCT03759860) | CynosureLutronic | 2018-01-08 |
| Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study (NCT03597815) | Uptown Eye Specialists | 2018-01-01 |
| The Results of Pars Plana Vitrectomy in Diabetic Macular Edema (NCT03384901) | Hillel Yaffe Medical Center | 2018-01-01 |
| Obstructive Sleep Apnea and Diabetic Macular Edema Inflammatory Mediators (NCT04648618) | Uptown Eye Specialists | 2018-01-01 |
| DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME (NCT03321513) | Jaeb Center for Health Research | 2017-12-07 |
| Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy (NCT03490318) | Belfast Health and Social Care Trust | 2017-10-26 |
| Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA (NCT03246152) | Cairo University | 2017-10-23 |
| Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME) (NCT03003416) | Allergan | 2017-10-19 |
| Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection (NCT03453281) | Indonesia University | 2017-10-10 |
| Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema (NCT05343156) | Oculis | 2017-09-18 |
| Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study) (NCT03394573) | Insel Gruppe AG, University Hospital Bern | 2017-09-16 |
| Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography (NCT03240458) | Assiut University | 2017-08-10 |
| Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema (NCT04387604) | Centro Hospitalar do Porto | 2017-08-01 |
| Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema (NCT03126786) | Clearside Biomedical, Inc. | 2017-07-11 |
| Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema (NCT04089605) | Far Eastern Memorial Hospital | 2017-06-01 |
| Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema (NCT03161652) | Carmen Clapp | 2017-05-24 |
| Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis (NCT03097068) | Vitreo-Retinal Associates, Michigan | 2017-04-19 |
| Diabetic Retinopathy Assessed by Ultra-wide (NCT03157206) | Association Pour La Recherche En Vision Du Service D'Ophtalmologie De L'Hôpital | 2017-04-19 |
| Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool (NCT03112005) | Eyenuk, Inc. | 2017-04-17 |
| Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser (NCT03143192) | Keyvan Koushan | 2017-03-08 |
| Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study (NCT02902744) | Johns Hopkins University | 2017-03-01 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept (NCT03056079) | Unity Health Toronto | 2017-02-28 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab (NCT03056092) | Unity Health Toronto | 2017-02-28 |
| Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (NCT04619303) | Lions Eye Institute, Perth, Western Australia | 2017-02-07 |
| 30g vs 33g Needle for Intravitreal Injections (NCT03038048) | Wills Eye | 2017-01-27 |
| Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates (NCT03590587) | Benha University | 2017-01-13 |
| Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema (NCT03975088) | University of Alexandria | 2017-01-01 |
| Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) (NCT04087746) | Minia University | 2017-01-01 |
| Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema (NCT03385382) | G. d'Annunzio University | 2016-12-06 |
| iOCT for Patients With Diabetic Macular Edema (NCT03328715) | Vienna Institute for Research in Ocular Surgery | 2016-12-01 |
| Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema (NCT04332133) | Minia University | 2016-12-01 |
| Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema (NCT02949024) | Clearside Biomedical, Inc. | 2016-11-10 |
| Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema (NCT02874859) | Lille Catholic University | 2016-11-09 |
| Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema (NCT02924987) | Maisonneuve-Rosemont Hospital | 2016-11-01 |
| Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections (NCT02951351) | Mayo Clinic | 2016-10-12 |
| Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study (NCT02511067) | University of Nebraska | 2016-10-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema (NCT02867735) | Novartis Pharmaceuticals | 2016-09-21 |
| Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema (NCT02842541) | Eleven Biotherapeutics | 2016-09-01 |
| Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) (NCT02914613) | OcuTerra Therapeutics, Inc. | 2016-08-24 |
| Identifying Patients With Unrecognized Treatable Diabetic Macular Edema (NCT01934920) | Elman Retina Group | 2016-08-01 |
| Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema (NCT02985619) | University of Sao Paulo | 2016-07-21 |
| OCT-angiography in Diabetic Patients (NCT02870803) | Retina Clinic, Sao Paulo, Brazil | 2016-07-01 |
| Adaptive Optics for Ophthalmic Technologies (NCT02826655) | Duke University | 2016-06-01 |
| Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial (NCT03608839) | Universidade Federal de Pernambuco | 2016-05-01 |
| A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema (NCT02699450) | Hoffmann-La Roche | 2016-04-27 |
| Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema (NCT04014556) | University of Alexandria | 2016-04-01 |
| One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab (NCT03974425) | University of Alexandria | 2016-04-01 |
| PROTECT2: Diabetes Care - Eye Exam (NCT03094819) | Retinal Care Inc. | 2016-03-17 |
| Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema (NCT02712008) | Regeneron Pharmaceuticals | 2016-03-02 |
| Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study (NCT02651168) | Unity Health Toronto | 2016-03-01 |
| Anti-VEGF Treatment for Prevention of PDR/DME (NCT02634333) | Jaeb Center for Health Research | 2016-01-01 |
| 3 Month Outcome of Ziv-aflibercept for DME (NCT02772497) | Marashi Eye Clinic | 2016-01-01 |
| Pain and Visual Outcome in Intravitreal Bevacizumab Injection (NCT02790775) | Shahid Beheshti University of Medical Sciences | 2015-12-01 |
| Aflibercept in Recurrent or Persistent CNV (NCT02669953) | Medical University of Vienna | 2015-12-01 |
| Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema (NCT02684084) | North Toronto Eye Care Laser and Eye Specialists | 2015-11-01 |
| Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide (NCT02221453) | Unity Health Toronto | 2015-09-01 |
| Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO (NCT02503540) | Justis Ehlers | 2015-08-18 |
| The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates (NCT02448446) | South Coast Retina Center; Carson, McBeath, Boswell, Inc. | 2015-08-01 |
| Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema (NCT02441907) | Unity Health Toronto | 2015-08-01 |
| SD-OCT Angiography (NCT02510885) | Duke University | 2015-07-01 |
| Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema (NCT02471651) | California Retina Consultants | 2015-06-01 |
| Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema (NCT02663141) | Tehran University of Medical Sciences | 2015-06-01 |
| IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab (NCT03340610) | Southeast Retina Center, Georgia | 2015-06-01 |
| Imaging Parameters and DME Treatment Response (NCT02637245) | Duke University | 2015-05-01 |
| Variable Interval Versus Set Interval Aflibercept for DME (NCT02392364) | California Retina Consultants | 2015-04-15 |
| Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (NCT02107131) | California Retina Consultants | 2015-03-13 |
| Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema (NCT03533478) | Catalysis SL | 2015-03-01 |
| The Effects of Intravitreal Ozurdex Implant in DME (NCT03475407) | Nune Eye Hospital, Seoul, Korea | 2015-03-01 |
| Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers (NCT02325271) | GWT-TUD GmbH | 2015-02-01 |
| Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. (NCT02571972) | Wills Eye | 2015-02-01 |
| Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia (NCT02232503) | Novartis Slovakia, s.r.o. | 2015-02-01 |
| A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) (NCT02302079) | Astellas Pharma Europe B.V. | 2015-01-12 |
| Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab (NCT03973138) | Sun Yat-sen University | 2015-01-01 |
| Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema. (NCT03458923) | Cairo University | 2015-01-01 |
| Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME (NCT02363621) | Arshad Khanani | 2015-01-01 |
| Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema (NCT04505306) | Moorfields Eye Hospital Centre Abu Dhabi | 2015-01-01 |
| 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema (NCT02406157) | Sun Yat-sen University | 2015-01-01 |
| The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema (NCT02796183) | Neon Hospital | 2015-01-01 |
| Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients (NCT02337972) | Sheba Medical Center | 2015-01-01 |
| Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME (NCT02262260) | Novartis Pharmaceuticals | 2014-12-12 |
| Spectral-domain Optical Coherence Tomography of the Eye (NCT02614625) | Augenabteilung Allgemeines Krankenhaus Linz | 2014-12-01 |
| Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial (NCT02299336) | Greater Houston Retina Research | 2014-11-24 |
| A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients (NCT02259088) | Novartis Pharmaceuticals | 2014-11-05 |
| The Endurance 1 Trial (NCT02297204) | Northern California Retina Vitreous Associates | 2014-11-01 |
| A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration (NCT02314299) | Stealth BioTherapeutics Inc. | 2014-11-01 |
| A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. (NCT03690050) | Belfast Health and Social Care Trust | 2014-11-01 |
| Comparison of Treatments in Diabetic Macular Edema (NCT05715385) | Babasaheb Ambedkar Memorial Hospital | 2014-11-01 |